{"id":"tp-59929","type":"article-newspaper","title":"Biogen’s Diranersen Data Show Slower Alzheimer’s Decline Over Two Years","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/59929","datePublished":"2026-11-17T23:06:59.000Z","dateModified":"2026-11-17T23:06:59.000Z","language":"en","abstract":"The Phase 2 open-label extension showed a 38% improvement in clinical benefit with a 60 mg regimen given twice yearly.","section":"Business","references":[]}